Prevalence rates of what GSK calls "deviant" sexual behaviours caused by the drugs are unknown and tend to be under-reported ...

Getting a headache and feeling sick are common side-effects for many medicines. Indulging in risky sexual behaviour or pathological gambling – not so common. But a BBC investigation has highlighted ...

Getting a headache and feeling sick are common side-effects for many medicines. Indulging in risky sexual behaviour or pathological gambling – not so common. But a BBC investigation has highlighted ...

Despite early success, Verona's lack of specific 2025 guidance and competition from Dupixent and other drugs raise concerns.

The study found that N6LS (VH3810109 or VH109), given every four months in combination with already marketed monthly ...

The deal includes two recently approved GSK products for metastatic melanoma ... lucrative and growing sectors in the industry. The UK-headquartered firm says this part of the deal represents ...

The global nicotine gums and mints market is projected to reach approximately USD 1,536.2 million by the end of 2024, with a ...

Coulter Partners, the global expert building leadership teams for Health, Science and Technology innovation businesses, ...

Getting a headache and feeling sick are common side-effects for many medicines. Indulging in risky sexual behaviour or pathological gambling - not so ...

A COMMON drug prescribed to treat restless leg syndrome and Parkinson’s can trigger disturbing side effects, experts have warned. Women have come forward reporting how the medicine has led ...

GlaxoSmithKline ... and current market value. The UK pharma first announced the “strategic review” of Horlicks and other consumer healthcare nutrition products in March this year.

TopBuild (BLD) is a Zacks Rank #5 (Strong Sell) after the company beat the Zacks Consensus Estimate when the last reported. The company is in the building products space and has faced a lot of ...